NASDAQ:XLO | Operating Income | Xilio Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$3.49M
2026-03-31-$14.11M
2025-12-31-$11.84M
2025-09-30-$1.93M
2025-06-30-$14.37M
2025-03-31-$13.85M
2024-12-31-$13.63M
2024-09-30-$14.76M
2024-06-30-$14.7M
2024-03-31-$17.49M
2023-12-31-$18.13M
2023-09-30-$17.36M
2023-06-30-$20.12M
2023-03-31-$23.53M
2022-12-31-$23.17M
2022-09-30-$20.21M
2022-06-30-$24.55M
2022-03-31-$21.22M
2021-12-31-$19.56M
2021-09-30-$15.96M
2021-06-30-$23.01M
2021-03-31-$16.52M
2020-12-31-$20.6M
2020-09-30-$14.62M

Annual Operating Income

DateOperating Income
2025-12-31-$41.98M
2024-12-31-$60.58M
2023-12-31-$79.13M
2022-12-31-$89.15M
2021-12-31-$75.04M
2020-12-31-$54.56M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.